3-50331753-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_007182.5(RASSF1):c.566G>A(p.Arg189Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,610,196 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007182.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASSF1 | NM_007182.5 | c.566G>A | p.Arg189Gln | missense_variant | 4/6 | ENST00000359365.9 | NP_009113.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASSF1 | ENST00000359365.9 | c.566G>A | p.Arg189Gln | missense_variant | 4/6 | 1 | NM_007182.5 | ENSP00000352323 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000600 AC: 15AN: 250110Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135474
GnomAD4 exome AF: 0.000107 AC: 156AN: 1457872Hom.: 2 Cov.: 33 AF XY: 0.000109 AC XY: 79AN XY: 724414
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.566G>A (p.R189Q) alteration is located in exon 4 (coding exon 4) of the RASSF1 gene. This alteration results from a G to A substitution at nucleotide position 566, causing the arginine (R) at amino acid position 189 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at